Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse

被引:39
|
作者
Meljon, Anna [1 ]
Wang, Yuqin [1 ]
Griffiths, William J. [1 ]
机构
[1] Swansea Univ, Coll Med, Inst Mass Spectrometry, Swansea SA2 8PP, W Glam, Wales
基金
英国生物技术与生命科学研究理事会;
关键词
24S-Hydroxycholesterol; 24R-Hydroxycholesterol; 24S; 25-Epoxycholesterol; Oxysterol; Brain; Cyp46a1; LIVER X RECEPTORS; MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; METABOLISM; TURNOVER; CELLS; BILE; 24S-HYDROXYCHOLESTEROL; 25-HYDROXYCHOLESTEROL; HOMEOSTASIS;
D O I
10.1016/j.bbrc.2014.01.153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxysterols are oxidised forms of cholesterol or its precursors. In this study we utilised the cholesterol 24-hydroxylase knockout mouse (Cyp46a1-/-) to study the sterol and oxysterol content of brain. Despite a great reduction in the abundance of 24S-hydroxycholesterol, the dominant metabolite of cholesterol in wild type brain, no other cholesterol metabolite was found to quantitatively replace this oxysterol in the Cyp46a1-/- mouse. Only minor amounts of other side-chain oxysterols including 22R-, 24R-, 25- and (25R),26-hydroxycholesterols were detected. In line with earlier studies, levels of cholesterol were similar in Cyp46a1-/- and wild type animals. However, the level of the cholesterol precursor, desomsterol, and its parallel metabolite formed via a shut of the mevalonate pathway, 24S,25-epoxycholesterol, were reduced in the Cyp46a1-/- mouse. The reduction in abundance of 24S,25-epoxycholesterol is interesting in light of a recent report indicating that this oxysterol promotes dopaminergic neurogenesis. (C) 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
引用
收藏
页码:768 / 774
页数:7
相关论文
共 50 条
  • [21] Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner
    Kosara Smiljanic
    Irena Lavrnja
    Aleksandra Mladenovic Djordjevic
    Sabera Ruzdijic
    Mirjana Stojiljkovic
    Sanja Pekovic
    Selma Kanazir
    Histochemistry and Cell Biology, 2010, 134 : 159 - 169
  • [22] Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
    Toshiya Nishi
    Shinichi Kondo
    Maki Miyamoto
    Sayuri Watanabe
    Shigeo Hasegawa
    Shigeru Kondo
    Jason Yano
    Etsurou Watanabe
    Tsuyoshi Ishi
    Masato Yoshikawa
    Haruhi Kamisaki Ando
    William Farnaby
    Shinji Fujimoto
    Eiji Sunahara
    Momoko Ohori
    Matthew J. During
    Takanobu Kuroita
    Tatsuki Koike
    Scientific Reports, 10
  • [23] Cholesterol 24-hydroxylase and apolipoprotein E gene polymorphisms in Alzheimer's disease in Hungarian population
    Juhász, A
    Rimanóczy, A
    Zana, M
    Bjelik, A
    Kálmán, J
    Gálfi, M
    Janka, Z
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S609 - S609
  • [24] ACIDOSIS ALTERS 1-ALPHA-HYDROXYLASE AND 24-HYDROXYLASE IN THE RAT
    CUNNINGHAM, J
    FAUSTO, A
    SCOTT, M
    AVIOLI, LV
    KIDNEY INTERNATIONAL, 1982, 21 (01) : 131 - 131
  • [25] Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
    Nishi, Toshiya
    Kondo, Shinichi
    Miyamoto, Maki
    Watanabe, Sayuri
    Hasegawa, Shigeo
    Kondo, Shigeru
    Yano, Jason
    Watanabe, Etsurou
    Ishi, Tsuyoshi
    Yoshikawa, Masato
    Ando, Haruhi Kamisaki
    Farnaby, William
    Fujimoto, Shinji
    Sunahara, Eiji
    Ohori, Momoko
    During, Matthew J.
    Kuroita, Takanobu
    Koike, Tatsuki
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] AAV gene therapy with cholesterol 24-hydroxylase attenuates Alzheimer phenotype in APP23 mice
    Hudry, Eloise
    Van Dam, Debby
    Kulik, Wim
    De Deyn, Peter Paul
    Stet, Femke
    Ahouansou, Ornella
    Benraiss, Abdellatif
    Delacourte, Andre
    Bougneres, Pierre
    Aubourg, Patrick
    Cartier, Nathalie
    HUMAN GENE THERAPY, 2008, 19 (10) : 1085 - 1086
  • [27] MECHANISM OF RENAL 24-HYDROXYLASE GENE-EXPRESSION
    SHINKI, T
    NAGAI, Y
    YAMATO, H
    NISHIMURA, A
    SUDA, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S223 - S223
  • [28] Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy
    Salamone, Alessia
    Terrone, Gaetano
    Di Sapia, Rossella
    Balosso, Silvia
    Ravizza, Teresa
    Beltrame, Luca
    Craparotta, Ilaria
    Mannarino, Laura
    Cominesi, Sara Raimondi
    Rizzi, Massimo
    Pauletti, Alberto
    Marchini, Sergio
    Porcu, Luca
    Zimmer, Till S.
    Aronica, Eleonora
    During, Matthew
    Abrahams, Brett
    Kondo, Shinichi
    Nishi, Toshiya
    Vezzani, Annamaria
    NEUROBIOLOGY OF DISEASE, 2022, 173
  • [29] Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice
    Hawkins, Nicole A.
    Jurado, Manuel
    Thaxton, Tyler T.
    Duarte, Samantha E.
    Barse, Levi
    Tatsukawa, Tetsuya
    Yamakawa, Kazuhiro
    Nishi, Toshiya
    Kondo, Shinichi
    Miyamoto, Maki
    Abrahams, Brett S.
    During, Matthew J.
    Kearney, Jennifer A.
    EPILEPSIA, 2021, 62 (11) : 2845 - 2857
  • [30] Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology
    Burlot, Marie-Anne
    Braudeau, Jerome
    Michaelsen-Preusse, Kristin
    Potier, Brigitte
    Ayciriex, Sophie
    Varin, Jennifer
    Gautier, Benoit
    Djelti, Fathia
    Audrain, Mickael
    Dauphinot, Luce
    Fernandez-Gomez, Francisco-Jose
    Caillierez, Raphaelle
    Laprevote, Olivier
    Bieche, Ivan
    Auzeil, Nicolas
    Potier, Marie-Claude
    Dutar, Patrick
    Korte, Martin
    Buee, Luc
    Blum, David
    Cartier, Nathalie
    HUMAN MOLECULAR GENETICS, 2015, 24 (21) : 5965 - 5976